Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related  | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | 
|---|---|---|---|---|---|
| 1 | Adipocytokine signaling pathway 💬 16 genes, 31 drugs (DrugBank) and 95 diseases  | 
JAK2 [1] JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 2 | AGE-RAGE signaling pathway in diabetic complications 💬 26 genes, 45 drugs (DrugBank) and 83 diseases  | 
JAK2 [1] JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 3 | Alcoholic liver disease 💬 39 genes, 46 drugs (DrugBank) and 87 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 4 | Alcoholic liver disease 💬 39 genes, 46 drugs (DrugBank) and 87 diseases  | 
C5AR1 [1] C5AR1 💬
 | 
Avacopan  Avacopan  💬
 | Avacopan | 043 [3] 43, 44, 222 💬
 | 
| 5 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 6 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 7 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 8 | Antifolate resistance 💬 8 genes, 21 drugs (DrugBank) and 66 diseases  | 
DHFR [2] DHFR, DHFR2 💬
 | 
Methotrexate  Methotrexate  💬
 | Methotrexate | 011 [38] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
 | 
| 9 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 10 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 11 | Autoimmune thyroid disease 💬 22 genes, 15 drugs (DrugBank) and 35 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 12 | Autoimmune thyroid disease 💬 22 genes, 15 drugs (DrugBank) and 35 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 13 | Autoimmune thyroid disease 💬 22 genes, 15 drugs (DrugBank) and 35 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 14 | Biosynthesis of cofactors 💬 10 genes, 10 drugs (DrugBank) and 51 diseases  | 
DHFR [2] DHFR, DHFR2 💬
 | 
Methotrexate  Methotrexate  💬
 | Methotrexate | 011 [38] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
 | 
| 15 | Cell adhesion molecules 💬 14 genes, 22 drugs (DrugBank) and 35 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 16 | cGMP-PKG signaling pathway 💬 46 genes, 119 drugs (DrugBank) and 118 diseases  | 
OPRD1 [1] OPRD1 💬
 | 
Naltrexone  Naltrexone  💬
 | Naltrexone | 006 [13]  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
 | 
| 17 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases  | 
JAK2 [1] JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 18 | Chemokine signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 51 diseases  | 
JAK2 [2] JAK2, JAK3 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 19 | Cholinergic synapse 💬 32 genes, 48 drugs (DrugBank) and 59 diseases  | 
JAK2 [1] JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 20 | Complement and coagulation cascades 💬 17 genes, 29 drugs (DrugBank) and 44 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 21 | Complement and coagulation cascades 💬 17 genes, 29 drugs (DrugBank) and 44 diseases  | 
C5AR1 [1] C5AR1 💬
 | 
Avacopan  Avacopan  💬
 | Avacopan | 043 [3] 43, 44, 222 💬
 | 
| 22 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 23 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases  | 
C5AR1 [1] C5AR1 💬
 | 
Avacopan  Avacopan  💬
 | Avacopan | 043 [3] 43, 44, 222 💬
 | 
| 24 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 25 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases  | 
JAK1 [2] JAK1, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 26 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 27 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 28 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases  | 
IL5RA [1] IL5RA 💬
 | 
Benralizumab  Benralizumab  💬
 | Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
 | 
| 29 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 30 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases  | 
TNFSF13B [1] TNFSF13B 💬
 | 
Belimumab  Belimumab  💬
 | Belimumab | 011 [13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
 | 
| 31 | Drug metabolism - other enzymes 💬 8 genes, 13 drugs (DrugBank) and 48 diseases  | 
IMPDH1 [2] IMPDH1, IMPDH2 💬
 | 
Mycophenolate mofetil  Mycophenolate mofetil  💬
 | Mycophenolate mofetil | 002 [34]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
 | 
| 32 | Drug metabolism - other enzymes 💬 8 genes, 13 drugs (DrugBank) and 48 diseases  | 
IMPDH1 [2] IMPDH1, IMPDH2 💬
 | 
Mycophenolic acid  Mycophenolic acid  💬
 | Mycophenolic acid | 002 [36]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
 | 
| 33 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 34 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases  | 
JAK1 [2] JAK1, JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 35 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases  | 
JAK1 [3] JAK1, JAK3, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 36 | Estrogen signaling pathway 💬 19 genes, 74 drugs (DrugBank) and 64 diseases  | 
OPRM1 [1] OPRM1 💬
 | 
Naltrexone  Naltrexone  💬
 | Naltrexone | 006 [13]  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
 | 
| 37 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 38 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 39 | Folate biosynthesis 💬 6 genes, 4 drugs (DrugBank) and 39 diseases  | 
DHFR [2] DHFR, DHFR2 💬
 | 
Methotrexate  Methotrexate  💬
 | Methotrexate | 011 [38] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
 | 
| 40 | Graft-versus-host disease 💬 7 genes, 22 drugs (DrugBank) and 60 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 41 | Growth hormone synthesis, secretion and action 💬 24 genes, 41 drugs (DrugBank) and 76 diseases  | 
JAK2 [1] JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 42 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 43 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 44 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases  | 
IL5RA [1] IL5RA 💬
 | 
Benralizumab  Benralizumab  💬
 | Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
 | 
| 45 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 46 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases  | 
MS4A1 [1] MS4A1 💬
 | 
Obinutuzumab  Obinutuzumab  💬
 | Obinutuzumab | 043 [4] 43, 44, 49, 222 💬
 | 
| 47 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases  | 
MS4A1 [1] MS4A1 💬
 | 
Rituximab  Rituximab  💬
 | Rituximab | 011 [48] 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
 | 
| 48 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases  | 
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 49 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases  | 
JAK1 [2] JAK1, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 50 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 51 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases  | 
JAK1 [3] JAK1, JAK2, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 52 | HIF-1 signaling pathway 💬 23 genes, 48 drugs (DrugBank) and 76 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 53 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 54 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases  | 
JAK1 [1] JAK1 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 55 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases  | 
JAK1 [2] JAK1, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 56 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases  | 
JAK1 [2] JAK1, JAK3 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 57 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 58 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 59 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 60 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 61 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases  | 
JAK1 [3] JAK1, JAK2, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 62 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 63 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 64 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 65 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases  | 
TNFSF13B [1] TNFSF13B 💬
 | 
Belimumab  Belimumab  💬
 | Belimumab | 011 [13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
 | 
| 66 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 67 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 68 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases  | 
IL5RA [1] IL5RA 💬
 | 
Benralizumab  Benralizumab  💬
 | Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
 | 
| 69 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 70 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases  | 
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 71 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases  | 
CD86 [1] CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 72 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases  | 
JAK1 [3] JAK1, JAK2, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 73 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases  | 
JAK1 [2] JAK1, JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 74 | Lipid and atherosclerosis 💬 46 genes, 56 drugs (DrugBank) and 93 diseases  | 
JAK2 [1] JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 75 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases  | 
JAK1 [3] JAK1, JAK3, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 76 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases  | 
DHFR [2] DHFR, DHFR2 💬
 | 
Methotrexate  Methotrexate  💬
 | Methotrexate | 011 [38] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
 | 
| 77 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases  | 
IMPDH1 [2] IMPDH1, IMPDH2 💬
 | 
Mycophenolate mofetil  Mycophenolate mofetil  💬
 | Mycophenolate mofetil | 002 [34]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
 | 
| 78 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases  | 
IMPDH1 [2] IMPDH1, IMPDH2 💬
 | 
Mycophenolic acid  Mycophenolic acid  💬
 | Mycophenolic acid | 002 [36]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
 | 
| 79 | Morphine addiction 💬 41 genes, 65 drugs (DrugBank) and 73 diseases  | 
OPRM1 [1] OPRM1 💬
 | 
Naltrexone  Naltrexone  💬
 | Naltrexone | 006 [13]  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
 | 
| 80 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases  | 
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 81 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 82 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases  | 
C5AR1 [1] C5AR1 💬
 | 
Avacopan  Avacopan  💬
 | Avacopan | 043 [3] 43, 44, 222 💬
 | 
| 83 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases  | 
NR3C1 [1] NR3C1 💬
 | 
Prednisolone  Prednisolone  💬
 | Prednisolone | 003 [42]  3 , 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
 | 
| 84 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases  | 
NR3C1 [1] NR3C1 💬
 | 
Prednisone  Prednisone  💬
 | Prednisone | 002 [45]  2 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
 | 
| 85 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases  | 
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬
 | 
Naltrexone  Naltrexone  💬
 | Naltrexone | 006 [13]  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
 | 
| 86 | Neutrophil extracellular trap formation 💬 35 genes, 36 drugs (DrugBank) and 61 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 87 | Neutrophil extracellular trap formation 💬 35 genes, 36 drugs (DrugBank) and 61 diseases  | 
C5AR1 [1] C5AR1 💬
 | 
Avacopan  Avacopan  💬
 | Avacopan | 043 [3] 43, 44, 222 💬
 | 
| 88 | NF-kappa B signaling pathway 💬 20 genes, 67 drugs (DrugBank) and 87 diseases  | 
TNFSF13B [1] TNFSF13B 💬
 | 
Belimumab  Belimumab  💬
 | Belimumab | 011 [13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
 | 
| 89 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases  | 
JAK1 [2] JAK1, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 90 | Non-alcoholic fatty liver disease 💬 23 genes, 47 drugs (DrugBank) and 86 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 91 | Non-small cell lung cancer 💬 21 genes, 33 drugs (DrugBank) and 45 diseases  | 
JAK3 [1] JAK3 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 92 | Nucleotide metabolism 💬 7 genes, 12 drugs (DrugBank) and 46 diseases  | 
IMPDH1 [2] IMPDH1, IMPDH2 💬
 | 
Mycophenolate mofetil  Mycophenolate mofetil  💬
 | Mycophenolate mofetil | 002 [34]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
 | 
| 93 | Nucleotide metabolism 💬 7 genes, 12 drugs (DrugBank) and 46 diseases  | 
IMPDH1 [2] IMPDH1, IMPDH2 💬
 | 
Mycophenolic acid  Mycophenolic acid  💬
 | Mycophenolic acid | 002 [36]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
 | 
| 94 | One carbon pool by folate 💬 3 genes, 2 drugs (DrugBank) and 38 diseases  | 
DHFR [2] DHFR, DHFR2 💬
 | 
Methotrexate  Methotrexate  💬
 | Methotrexate | 011 [38] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
 | 
| 95 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases  | 
JAK1 [2] JAK1, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 96 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases  | 
JAK1 [1] JAK1 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 97 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 98 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 99 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases  | 
IL5RA [1] IL5RA 💬
 | 
Benralizumab  Benralizumab  💬
 | Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
 | 
| 100 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 101 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases  | 
JAK1 [3] JAK1, JAK2, JAK3 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 102 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases  | 
JAK1 [2] JAK1, JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 103 | Pertussis 💬 18 genes, 38 drugs (DrugBank) and 66 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 104 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 105 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases  | 
JAK1 [3] JAK1, JAK2, JAK3 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 106 | Primary immunodeficiency 💬 11 genes, 23 drugs (DrugBank) and 26 diseases  | 
JAK3 [1] JAK3 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 107 | Prion disease 💬 41 genes, 66 drugs (DrugBank) and 107 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 108 | Prolactin signaling pathway 💬 19 genes, 39 drugs (DrugBank) and 54 diseases  | 
JAK2 [1] JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 109 | Purine metabolism 💬 29 genes, 35 drugs (DrugBank) and 73 diseases  | 
IMPDH1 [2] IMPDH1, IMPDH2 💬
 | 
Mycophenolate mofetil  Mycophenolate mofetil  💬
 | Mycophenolate mofetil | 002 [34]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
 | 
| 110 | Purine metabolism 💬 29 genes, 35 drugs (DrugBank) and 73 diseases  | 
IMPDH1 [2] IMPDH1, IMPDH2 💬
 | 
Mycophenolic acid  Mycophenolic acid  💬
 | Mycophenolic acid | 002 [36]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
 | 
| 111 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 112 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 113 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases  | 
TNFSF13B [1] TNFSF13B 💬
 | 
Belimumab  Belimumab  💬
 | Belimumab | 011 [13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
 | 
| 114 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases  | 
JAK1 [3] JAK1, JAK2, JAK3 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 115 | Sphingolipid signaling pathway 💬 30 genes, 52 drugs (DrugBank) and 73 diseases  | 
OPRD1 [1] OPRD1 💬
 | 
Naltrexone  Naltrexone  💬
 | Naltrexone | 006 [13]  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
 | 
| 116 | Staphylococcus aureus infection 💬 12 genes, 19 drugs (DrugBank) and 34 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 117 | Staphylococcus aureus infection 💬 12 genes, 19 drugs (DrugBank) and 34 diseases  | 
C5AR1 [1] C5AR1 💬
 | 
Avacopan  Avacopan  💬
 | Avacopan | 043 [3] 43, 44, 222 💬
 | 
| 118 | Systemic lupus erythematosus 💬 14 genes, 38 drugs (DrugBank) and 78 diseases  | 
C5 [1] C5 💬
 | 
Vilobelimab  Vilobelimab  💬
 | Vilobelimab | 043 [3] 43, 44, 269 💬
 | 
| 119 | Systemic lupus erythematosus 💬 14 genes, 38 drugs (DrugBank) and 78 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 120 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 121 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 122 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases  | 
IL5 [1] IL5 💬
 | 
Mepolizumab  Mepolizumab  💬
 | Mepolizumab | 044 [4] 44, 45, 98, 162 💬
 | 
| 123 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases  | 
IL5 [1] IL5 💬
 | 
Reslizumab  Reslizumab  💬
 | Reslizumab | 044 [2] 44, 98 💬
 | 
| 124 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases  | 
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 125 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 126 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases  | 
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 127 | Toll-like receptor signaling pathway 💬 36 genes, 46 drugs (DrugBank) and 65 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 128 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases  | 
JAK1 [3] JAK1, JAK2, TYK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 129 | Transcriptional misregulation in cancer 💬 26 genes, 49 drugs (DrugBank) and 76 diseases  | 
CD86 [1] CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 130 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases  | 
JAK1 [2] JAK1, JAK2 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 131 | Type I diabetes mellitus 💬 11 genes, 22 drugs (DrugBank) and 68 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 132 | Viral carcinogenesis 💬 25 genes, 23 drugs (DrugBank) and 40 diseases  | 
JAK1 [2] JAK1, JAK3 💬
 | 
Tofacitinib  Tofacitinib  💬
 | Tofacitinib | 011 [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 133 | Viral myocarditis 💬 10 genes, 19 drugs (DrugBank) and 46 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 134 | Viral protein interaction with cytokine and cytokine receptor 💬 17 genes, 29 drugs (DrugBank) and 60 diseases  | 
IL6R [1] IL6R 💬
 | 
Tocilizumab  Tocilizumab  💬
 | Tocilizumab | 002 [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 135 | Virion - Adenovirus 💬 2 genes, 2 drugs (DrugBank) and 26 diseases  | 
CD80 [2] CD80, CD86 💬
 | 
Abatacept  Abatacept  💬
 | Abatacept | 011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 |